breast cancer

February 10, 2020

Imaging breast cancer cell size

A noninvasive MRI approach assesses breast tumor cell size and could be a useful way to evaluate early response to neoadjuvant therapy.

By Leigh MacMillan
January 23, 2020

HDL-cholesterol and breast cancer risk

Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy.

By Leigh MacMillan
January 16, 2020

ACMG issues statement on breast cancer genetic testing

According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.

By Tom Wilemon
December 13, 2019

The American College of Medical Genetics and Genomics advises evaluating all breast cancer patients to determine the need for genetic testing

According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.

By Tom Wilemon
November 20, 2019

Study finds breast cancer recurrence score has different implications for men

A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer

By Tom Wilemon
Research by David Page, MD, helped dramatically alter the way breast cancer risk is assessed.
October 24, 2019

Breast cancer research pioneer Page remembered

David Page, MD, former professor of Pathology and Preventive Medicine at Vanderbilt University School of Medicine, whose work revolutionized the assessment of breast cancer risk, died in Nashville on Thursday, Oct. 17. He was 78.

By Bill Snyder
October 24, 2019

Pietenpol, Wilson land Komen cancer research support

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.
By Tom Wilemon
October 22, 2019

Another way to detect lymphedema

Early detection of lymphedema, which occurs in 20% of patients following breast cancer treatment, may improve therapeutic options for patients.
By Sanjay Mishra
October 17, 2019

Study finds men have higher mortality rate after breast cancer diagnosis

A new study shows men with breast cancer are more likely to die than their female counterparts, across all stages of disease.
By Tom Wilemon
October 10, 2019

Study examines pain processing in co-occurring cancer, Alzheimer’s disease

A new multisite study will examine whether co-occurring Alzheimer’s disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.
By Kelsey Herbers
September 5, 2019

Study backs genetic testing for all metastatic breast cancer patients

By Tom Wilemon
August 27, 2019

A “rheostat” for cancer signals

Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.
By Sanjay Mishra
July 8, 2019

Clinical study tests drug that may prevent cancer metastasis

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.
By Leigh MacMillan
1 2 3 4 5 6 … 12